total
cf
patient
femal
male
median
age
year
rang
month
year
enrol
studi
septemb
septemb
nasopharyng
aspir
npa
nasal
blow
nb
specimen
viral
investig
well
sputum
oropharyng
sampl
microbiolog
cultur
collect
schedul
unschedul
visit
occas
median
sd
visit
rang
visit
per
patient
local
ethic
committe
approv
studi
protocol
parentsguardian
gave
inform
consent
children
particip
studi
clinic
function
data
obtain
visit
exacerb
respiratori
diseas
defin
presenc
follow
symptom
sign
fever
increas
amount
secret
cough
intens
chang
sputum
aspect
worsen
dyspnea
loss
appetit
decreas
forc
expiratori
volum
second
weight
loss
total
nucleic
acid
extract
nasopharyng
sampl
qiamp
viral
rna
mini
kit
qiagen
hamburg
germani
accord
manufactur
instruct
revers
transcript
perform
high
capac
cdna
archiv
kit
appli
biosystem
foster
citi
ca
use
previous
extract
rna
identif
respiratori
virus
perform
individu
polymeras
chain
reaction
pcr
target
rsv
influenza
virus
b
human
parainfluenza
virus
hcov
human
metapneumoviru
adenoviru
human
bocaviru
enterovirus
gene
previous
describ
analyt
sensit
assay
hcov
detect
determin
quantifi
plasmid
standard
copi
per
reaction
coronavirusposit
sampl
confirm
mean
revers
pcr
use
primer
cttatgggttgggattatcc
taataacagacaacgccatcatc
first
round
inner
primer
ccatcatcactcagaatcatca
b
ccatcatcagaaagaatcatca
gener
pair
amplicon
rnadepend
rna
polymeras
rdrp
gene
nucleotid
sequenc
perform
use
dye
termin
chemistri
appli
biosystem
nucleic
acid
align
conduct
basi
amino
acid
code
use
blosum
algorithm
phylogenet
classif
perform
use
neighborjoin
method
percentag
distanc
substitut
model
bootstrap
valu
calcul
replic
mega
softwar
wwwmegasoftwarenet
nucleotid
sequenc
partial
rdrp
gene
hcov
identifi
studi
submit
genbank
access
number
result
express
median
percentag
unless
state
otherwis
categor
variabl
analyz
fisher
exact
test
age
differ
patient
patient
without
hcov
within
hcov
speci
compar
nonparametr
test
proport
case
acut
respiratori
exacerb
among
patient
infect
differ
hcov
speci
compar
fisher
exact
test
logist
regress
use
determin
whether
infect
hcov
gener
one
particular
hcov
speci
independ
associ
respiratori
exacerb
hospit
admiss
account
correl
among
sampl
within
subject
binomi
gener
linear
model
use
analys
perform
use
spss
window
version
spss
chicago
il
level
statist
signific
set
least
respiratori
viru
identifi
sampl
rhinoviru
main
identifi
agent
sampl
hcov
identifi
sampl
patient
male
femal
shown
figur
virus
two
patient
separ
identif
hcov
sampl
collect
month
apart
respect
differ
speci
identifi
occas
singl
hcov
infect
found
occas
coinfect
observ
occas
four
identif
virus
rhinoviru
enteroviru
two
virus
identifi
rsv
rhinoviru
influenza
viru
enteroviru
overal
episod
respiratori
exacerb
identifi
hospit
admiss
occur
signific
associ
found
increas
risk
respiratori
exacerb
rhinoviru
c
identifi
increas
risk
hospit
admiss
influenza
viru
infect
data
shown
signific
differ
found
among
patient
hcov
infect
exacerb
identifi
occas
hospit
admiss
occas
hcov
speci
found
display
tabl
patient
characterist
includ
frequenc
symptom
clinic
statu
time
visit
age
distribut
similar
among
patient
infect
differ
hcov
speci
although
signific
differ
found
among
age
patient
without
viral
infect
infect
hcov
virus
tabl
although
signific
differ
seen
concern
report
symptom
clinic
find
among
patient
infect
differ
hcov
speci
significantli
greater
respiratori
exacerb
rate
found
among
patient
infect
compar
infect
hcov
speci
p
logist
regress
model
howev
neither
identif
hcov
specif
could
demonstr
significantli
associ
respiratori
exacerb
first
descript
identif
new
hcov
speci
among
patient
cf
signific
clinic
impact
could
attribut
infect
speci
whole
identif
associ
significantli
higher
rate
respiratori
exacerb
compar
hcov
speci
although
hcov
previous
identifi
caus
agent
lower
respiratori
tract
infect
medic
commun
commonli
knew
common
cold
virus
identif
new
speci
hcov
emerg
sar
hcov
highlight
potenti
role
virus
caus
agent
sever
lower
respiratori
tract
infect
follow
initi
descript
new
nonsar
hcov
sever
studi
describ
preval
clinic
impact
publish
although
result
conflict
preval
valu
new
oscil
report
sever
case
lower
respiratori
infect
describ
australia
germani
howev
studi
clinic
impact
differ
hcov
speci
perform
among
children
hospit
acut
respiratori
tract
infect
small
sampl
size
short
period
sampl
collect
recent
studi
includ
much
larger
sampl
gaunt
et
al
studi
respiratori
sampl
obtain
edinburgh
unit
kingdom
found
least
coronaviru
sampl
mark
predomin
winter
month
although
found
signific
number
coinfect
mainli
rsv
singl
infect
specif
associ
lower
respiratori
tract
diseas
also
observ
identifi
smaller
proport
sampl
predomin
among
immunosuppress
patient
talbot
et
al
use
molecular
tool
determin
incid
clinic
featur
upper
lower
respiratori
tract
infect
associ
period
show
associ
signific
burden
lower
respiratori
tract
infect
previous
healthi
outpati
children
manifest
clinic
syndrom
pneumonia
bronchiol
similar
caus
respiratori
virus
patient
cf
repres
specif
popul
suscept
sever
clinic
manifest
respiratori
infect
overal
limit
mucocilliari
transport
anatom
distort
bronchial
tree
facilit
retent
infect
respiratori
secret
impact
respiratori
virus
cf
lung
diseas
recent
reassess
use
molecular
method
research
conflict
result
olesen
et
al
report
lack
signific
clinic
impact
viral
infect
lung
function
respiratori
symptom
wat
et
al
describ
associ
viral
infect
respiratori
exacerb
cf
children
particularli
influenza
viru
influenza
b
viru
rhinoviru
infect
identifi
one
possibl
explan
differenti
clinic
impact
respiratori
virus
cf
patient
baselin
lung
function
possibl
patient
wors
lung
diseas
would
risk
present
exacerb
rule
possibl
present
studi
small
number
patient
infect
hcov
anoth
hypothesi
relat
mechan
diseas
hcov
sar
coronaviru
use
angiotensinconvert
enzym
main
pathway
attach
entri
follow
infect
substanti
reduct
express
cell
surfac
occur
rate
intens
downregul
seem
much
lower
infect
compar
sar
coronaviru
infect
downregul
previous
shown
associ
increas
inflammatori
process
respiratori
tract
may
one
determin
sever
acut
respiratori
distress
syndrom
moreov
genet
polymorph
associ
increas
ace
express
counterbal
action
proinflammatori
mediat
shown
associ
wors
lung
diseas
cf
patient
previous
shown
human
rhinoviru
c
infect
associ
increas
risk
respiratori
exacerb
cf
children
although
could
identifi
signific
associ
hcov
infect
respiratori
exacerb
present
analysi
exacerb
observ
signific
proport
children
mention
mean
age
patient
approxim
year
studi
talbot
et
al
greatest
incid
lri
associ
virus
occur
month
age
therefor
studi
infant
cf
could
produc
differ
result
conclus
found
circul
speci
hcov
children
cf
enrol
studi
symptom
mainli
relat
upper
airway
find
associ
hcov
infect
gener
infect
given
hcov
speci
increas
risk
respiratori
exacerb
hospit
admiss
although
significantli
higher
rate
respiratori
exacerb
observ
among
children
compar
children
infect
coronavirus
